Background: We developed an economic model of prostate cancer management from
diagnosis until death. We have used the Montreal Prostate Cancer Model to estimate the …

Objectives: The incidence of prostate cancer is increasing, as is the number of diagnostic
and therapeutic interventions to manage this disease. We developed a Markov state …

Purpose To estimate the health system costs of prostate cancer by disease risk category and
treatment type over 2016 to 2025 and to identify potential strategies to contain the cost …

Study Type–Health Economic (multiway sensitivity analyses) Level of Evidence 2b
OBJECTIVE To estimate the total healthcare costs and costs attributable to prostate cancer …

What's known on the subject? and What does the study add? Prostate cancer is the most
common malignancy in men. Treatment is costly; the majority of men are treated with …

Abstract BACKGROUND In the United States in 2000, 180,400 new cases of prostate
carcinoma were expected to occur, with 31,900 men expected to die from this illness. In …

BACKGROUND Prostate cancer is the most common malignancy diagnosed among men in
the United States. This article reviews previous studies of the annual cost of all cancers and …

Prostate cancer is an important disease in terms of economic implications because of its
increasing incidence and health care costs. We assessed the direct costs of the clinical …

Abstract Background Prostate cancer (PCa) is the most common cancer affecting men in the
United States. The initial treatment and subsequent monitoring of PCa patients places a …

The economic burden of prostate cancer is substantial and growing. The diagnosis of new
cases has been increasing at an exponential rate since 1990, largely as the result of …